01 / 04Discover
Cohort discovery
Find relevant public studies across tissue, disease, assay, and experimental context.
Applications
Better context enables better biological questions.
Reomics is being developed for teams that need to understand what public transcriptomic evidence exists before committing to the next experiment or program decision.
Research workflows
One foundation, multiple lines of inquiry.
Each application begins with a trustworthy definition of the samples and studies being compared.
02 / 04Investigate
Target research
Bring comparable expression and splicing evidence to early target questions.
03 / 04Explore
RNA therapeutics
Explore exon and splice-site evidence in cohorts relevant to RNA-directed strategies.
04 / 04Evaluate
Biomarker research
Study disease-associated transcriptomic patterns with clearer cohort definitions.
RNA-directed research
Look beyond gene-level summaries.
For RNA therapeutics and splice-targeting questions, exon and junction information can help characterize relevant biology. The deck identifies neuromuscular and neurodevelopmental settings as example areas for cohort exploration.
Reomics aims to connect those signals to well-described disease, tissue, treatment, and study contexts. These are research workflows under development, not clinical claims.
For research teams
Scope an evidence landscape
Find relevant public studies and understand where sample definitions or metadata uncertainty affect interpretation.
For partners
Prioritize deeper processing
Identify cohorts that merit targeted Monorail processing and a closer look at expression or splicing patterns.
Work with Reomics
Start a conversation Bring us your research question.
We welcome conversations with biotechnology and pharmaceutical teams, researchers, and prospective collaborators.